Assessing Lazard (LAZ) Valuation After Mixed Q1 2026 Results Weigh On Investor Sentiment
Lazard Inc LAZ | 0.00 |
What the mixed Q1 report means for Lazard (LAZ) stock
Lazard (LAZ) reported mixed Q1 2026 results, with a strong revenue outcome but adjusted earnings per share below analyst expectations, a combination that helped drive a recent 7.8% drop in the stock.
Over the past year, Lazard’s total shareholder return of 11.2% contrasts with a 6.6% year to date share price decline and a 12.8% 1 month share price gain. This suggests momentum has recently cooled but not reversed the longer term trend.
If the recent volatility in Lazard has you reassessing your watchlist, this can be a useful moment to broaden your search and check out 18 top founder-led companies
With Lazard trading at $46.44 against an analyst price target of $52.38 and an intrinsic value estimate at a wider discount, investors now face a key question: is this a buying opportunity, or is the market already pricing in future growth?
Most Popular Narrative: 11.3% Undervalued
With Lazard’s shares at $46.44 versus a narrative fair value of $52.38, the current valuation sits below what the most followed narrative implies.
Lazard's diversification in M&A, non-M&A, and global operations allows the firm to adapt to changing market conditions and capture opportunities across different regions, potentially stabilizing revenues amidst economic uncertainties. Growth in Lazard's financial advisory backlog, particularly in Europe, combined with a diversified business model across geographic and product lines, could buoy revenues even if specific markets face challenges.
Analysts are building this fair value around expectations for faster revenue expansion, higher margins, and a higher earnings multiple, all pulled back to today using an 8.94% discount rate. Want to see how those moving parts fit together and which assumptions really carry the valuation story?
Result: Fair Value of $52.38 (UNDERVALUED)
However, this narrative can crack if expansion efforts in regions like the Middle East and alliances in Europe increase costs faster than related revenues materialize.
Next Steps
Mixed signals or the early stage of a stronger story: either way, it pays to move quickly, review the underlying data, and weigh 3 key rewards and 2 important warning signs
Looking for more investment ideas?
If Lazard is already on your radar, do not stop there. The right screener can surface opportunities you might not notice by only scrolling through headlines.
- Target income you can plan around by checking out 12 dividend fortresses, built to highlight companies with yields that stand out.
- Explore value that appears grounded in solid fundamentals through the screener containing 23 high quality undiscovered gems before the crowd starts paying closer attention.
- Focus on peace of mind as well as potential upside by starting with the 72 resilient stocks with low risk scores and concentrating on companies with more resilient profiles.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
